DE301413C - - Google Patents
Info
- Publication number
- DE301413C DE301413C DENDAT301413D DE301413DA DE301413C DE 301413 C DE301413 C DE 301413C DE NDAT301413 D DENDAT301413 D DE NDAT301413D DE 301413D A DE301413D A DE 301413DA DE 301413 C DE301413 C DE 301413C
- Authority
- DE
- Germany
- Prior art keywords
- animal
- serum
- carcinoma
- ferments
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002966 serum Anatomy 0.000 claims description 18
- 201000009030 Carcinoma Diseases 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 230000007123 defense Effects 0.000 claims description 7
- 201000011510 cancer Diseases 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000035876 healing Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 206010039491 Sarcoma Diseases 0.000 claims description 2
- 238000010348 incorporation Methods 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 20
- 210000001519 tissue Anatomy 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE301413C true DE301413C (en, 2012) |
Family
ID=555290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT301413D Active DE301413C (en, 2012) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE301413C (en, 2012) |
-
0
- DE DENDAT301413D patent/DE301413C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69709682T2 (de) | Gruene salbe | |
| DE68918922T3 (de) | Biologische Unterlage für Zellkulturen, bestehend aus durch Thrombin koagulierte Plasmaproteine, ihre Verwendung für die Keratinozytenkultur, deren Rückgewinnung und Transport für therapeutische Verwendungszwecke. | |
| DE2655844C3 (de) | Verfahren zur Herstellung antitumorwirksamer Substanzen | |
| DE301413C (en, 2012) | ||
| DE60030567T2 (de) | Aus muskeln abstammenden wirkstoffe enthaltende zusammensetzung | |
| AT87794B (de) | Verfahren zur Herstellung fermenthaltiger Tiersera. | |
| DE3000521A1 (de) | Substanz mit interferon induzierender aktivitaet sowie verfahren zu ihrer herstellung | |
| CH91726A (de) | Verfahren zur Herstellung eines fermenthaltigen Tierserums. | |
| AT392003B (de) | Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat | |
| CH639280A5 (de) | Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom. | |
| AT114176B (de) | Verfahren zur Gewinnung von Schutz- und Heilmitteln aus drüsigen Organen. | |
| DE69825433T2 (de) | Aktive substanz für inhibierung von tumoröse proliferation im geweben aus der ektoderm | |
| DE69006741T2 (de) | Reines protein und bioaktive pharmazeutische produkte. | |
| DE832321C (de) | Verfahren zur Gewinnung eines Arzneimittels zur Behandlung von auf hemmungslosem Wachstum von Zellen o. dgl. beruhenden Erkrankungen, wie Leukaemie usw. | |
| DE862942C (de) | Verfahren zur Herstellung eines Gewebeextraktes und eines durch diesen Extrakt stimulierten Serums | |
| DE216310C (en, 2012) | ||
| DE238995C (en, 2012) | ||
| AT200257B (en, 2012) | ||
| DE874061C (de) | Verfahren zur Herstellung einer blutgerinnungsfoerdernden Substanz aus Lunge | |
| DE320857C (de) | Verfahren zur Darstellung von stickstoffhaltigen Verbindungen aus Corpus Iuteum | |
| DE336051C (de) | Verfahren zur Herstellung von Heil- und Schutzstoffen gegen Tuberkulose | |
| DE1802386A1 (de) | Verfahren zur Gewinnung von cytobiotischen Globulinen aus tierischen Organen | |
| DE499512C (de) | Verfahren zur Herstellung von oertlich anzuwendenden, aus Bakterienkulturen, z.B. Staphylokokken-, Streptokokkenkulturen usw. gewonnenen, selbst aber bakterienfreien, sterilen, hochbestaendigen Impfstoffen (Topovaccinen) | |
| AT144187B (de) | Verfahren zur Herstellung von polyvalenten Impfstoffen aus Keuchhustenbazillen (Bordet-Gengou). | |
| DE885127C (de) | Verfahren zur Herstellung eines Gewebeextraktes und eines durch diesen Extrakt stimulierten Serums |